Svein Dueland

8.1k total citations · 1 hit paper
173 papers, 5.5k citations indexed

About

Svein Dueland is a scholar working on Oncology, Surgery and Hepatology. According to data from OpenAlex, Svein Dueland has authored 173 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Oncology, 82 papers in Surgery and 50 papers in Hepatology. Recurrent topics in Svein Dueland's work include Hepatocellular Carcinoma Treatment and Prognosis (49 papers), Colorectal Cancer Treatments and Studies (38 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (33 papers). Svein Dueland is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (49 papers), Colorectal Cancer Treatments and Studies (38 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (33 papers). Svein Dueland collaborates with scholars based in Norway, United States and Denmark. Svein Dueland's co-authors include Pål‐Dag Line, Morten Hagness, Aksel Foss, Marianne G. Guren, Kjersti Flatmark, Harald Grut, Roger J. Davis, Steinar Aamdal, Stein Gunnar Larsen and Gustav Gaudernack and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Svein Dueland

168 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study

2012 714 citations Halfdan Sørbye, Seppo W. Langer et al. Annals of Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Svein Dueland Norway	40	2.9k	2.1k	1.4k	1.2k	1.0k	173	5.5k
Sanjay Kakar United States	52	3.0k 1.0×	2.3k 1.1×	1.5k 1.1×	1.7k 1.5×	1.5k 1.5×	165	6.9k
Hirohisa Okabe Japan	37	1.7k 0.6×	1.8k 0.9×	1.8k 1.3×	1.2k 1.0×	1.2k 1.2×	253	4.8k
Benjamin Tan United States	33	2.9k 1.0×	1.6k 0.8×	543 0.4×	434 0.4×	829 0.8×	163	5.0k
Peter Metrakos Canada	32	2.5k 0.8×	941 0.4×	620 0.5×	2.2k 1.8×	1.5k 1.5×	136	5.4k
Thomas Aparicio France	40	3.6k 1.2×	1.8k 0.8×	370 0.3×	1.5k 1.3×	716 0.7×	254	6.5k
Chun‐Nan Yeh Taiwan	41	1.7k 0.6×	2.7k 1.3×	727 0.5×	676 0.6×	880 0.9×	280	5.5k
Nirag Jhala United States	41	3.2k 1.1×	2.4k 1.1×	308 0.2×	1.4k 1.2×	1.0k 1.0×	165	6.0k
Tetsuo Ohta Japan	46	3.7k 1.2×	3.0k 1.4×	522 0.4×	1.1k 1.0×	1.9k 1.9×	338	7.3k
David J. Pinato United Kingdom	38	3.0k 1.0×	791 0.4×	2.2k 1.6×	1.4k 1.2×	1.3k 1.2×	233	6.3k
Toshifumi Wakai Japan	44	2.2k 0.8×	2.6k 1.2×	774 0.6×	658 0.6×	1.7k 1.7×	346	6.0k

Countries citing papers authored by Svein Dueland

Since Specialization

Citations

This map shows the geographic impact of Svein Dueland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Svein Dueland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Svein Dueland more than expected).

Fields of papers citing papers by Svein Dueland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Svein Dueland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Svein Dueland. The network helps show where Svein Dueland may publish in the future.

Co-authorship network of co-authors of Svein Dueland

This figure shows the co-authorship network connecting the top 25 collaborators of Svein Dueland. A scholar is included among the top collaborators of Svein Dueland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Svein Dueland. Svein Dueland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Serenari, Matteo, Jacopo Lanari, Svein Dueland, et al.. (2025). Liver Transplantation Versus ALPPS for Colorectal Liver Metastases. Annals of Surgery. 283(3). 357–364.

Vitale, Alessandro, Jacopo Lanari, Umberto Cillo, et al.. (2025). Sex-based differences in survival after liver transplantation for colorectal cancer liver metastases: A multivariable analysis. JHEP Reports. 7(10). 101505–101505. 2 indexed citations

Dueland, Svein, et al.. (2024). The prognostic value of [¹⁸F]FDG PET/CT texture analysis prior to transplantation for unresectable colorectal liver metastases. Clinical Physiology and Functional Imaging. 45(1). e12908–e12908.

Kleive, Dyre, Caroline S. Verbeke, Lars Aabakken, et al.. (2023). Resection rates and intention-to-treat outcomes in borderline and locally advanced pancreatic cancer: real-world data from a population-based, prospective cohort study (NORPACT-2). BJS Open. 7(6). 9 indexed citations

Dueland, Svein, et al.. (2023). Long-Term Survival, Prognostic Factors, and Selection of Patients With Colorectal Cancer for Liver Transplant. JAMA Surgery. 158(9). e232932–e232932. 36 indexed citations

Halazun, Karim J., Jerry L. Hubbard, Darius F. Mirza, et al.. (2022). Liver Transplantation for Non-Resectable Colorectal Liver Metastases: The International Hepato-Pancreato-Biliary Association Consensus Guidelines. HPB. 24. S17–S17. 4 indexed citations

Meltzer, Sebastian, Anne Negård, Kjersti Flatmark, et al.. (2019). Sex-related differences in primary metastatic site in rectal cancer; associated with hemodynamic factors?. Clinical and Translational Radiation Oncology. 21. 5–10. 8 indexed citations

Andersson, Yvonne, Stein Gunnar Larsen, Ben Davidson, et al.. (2019). ImmunoPeCa trial: Long-term outcome following intraperitoneal MOC31PE immunotoxin treatment in colorectal peritoneal metastasis. European Journal of Surgical Oncology. 47(1). 134–138. 20 indexed citations

Meltzer, Sebastian, Ying Esbensen, Svein Dueland, et al.. (2018). Markers of Mitochondrial Metabolism in Tumor Hypoxia, Systemic Inflammation, and Adverse Outcome of Rectal Cancer. Translational Oncology. 12(1). 76–83. 16 indexed citations

10.

Andersson, Yvonne, Stein Gunnar Larsen, Ben Davidson, et al.. (2017). Novel Treatment with Intraperitoneal MOC31PE Immunotoxin in Colorectal Peritoneal Metastasis: Results From the ImmunoPeCa Phase 1 Trial. Annals of Surgical Oncology. 24(7). 1916–1922. 24 indexed citations

11.

Dueland, Svein, et al.. (2017). TG01/GM-CSF and adjuvant gemcitabine in patients with resected RAS-mutant adenocarcinoma of the pancreas. Annals of Oncology. 28. v227–v228. 3 indexed citations

12.

Kalanxhi, Erta, Svein Dueland, Solveig Norheim Andersen, et al.. (2016). Induction of Apoptosis in Intestinal Toxicity to a Histone Deacetylase Inhibitor in a Phase I Study with Pelvic Radiotherapy. Cancer Research and Treatment. 49(2). 374–386. 4 indexed citations

13.

Line, Pål‐Dag, Morten Hagness, Jon Magnus Solheim, & Svein Dueland. (2016). A novel technique for partial liver transplantation and two stage hepatectomy in non-resectable malignant tumors of the liver: The RAPID concept. HPB. 18. e14–e14. 2 indexed citations

14.

Ree, Anne Hansen, Sebastian Meltzer, Kjersti Flatmark, Svein Dueland, & Erta Kalanxhi. (2014). Biomarkers of Treatment Toxicity in Combined-Modality Cancer Therapies with Radiation and Systemic Drugs: Study Design, Multiplex Methods, Molecular Networks. International Journal of Molecular Sciences. 15(12). 22835–22856. 10 indexed citations

15.

Hagness, Morten, Aksel Foss, Pål‐Dag Line, et al.. (2013). Liver Transplantation for Nonresectable Liver Metastases From Colorectal Cancer. Annals of Surgery. 257(5). 800–806. 244 indexed citations

16.

Sørbye, Halfdan, Staffan Welin, Seppo W. Langer, et al.. (2013). Ki-67 Proliferative Index Predicts Response to Chemotherapy and Survival in 252 Patients with High-Grade Gastrointestinal Neuroendocrine Carcinoma (WHO G3). Pancreas. 42(2). 382–382. 2 indexed citations

17.

Kyte, Jon Amund, Gustav Gaudernack, Svein Dueland, et al.. (2011). Telomerase Peptide Vaccination Combined with Temozolomide: A Clinical Trial in Stage IV Melanoma Patients. Clinical Cancer Research. 17(13). 4568–4580. 92 indexed citations

18.

Nilsson, Bo, Alain Hendlisz, Steinar Aamdal, et al.. (2009). First-in-human study of a novel nucleoside analogue, CP-4126, in patients with advanced solid tumors. Journal of Clinical Oncology. 27(15_suppl). 2577–2577. 4 indexed citations

19.

Raymond, Éric, Svein Dueland, Michael Lind, et al.. (2005). Pharmacokinetics of a nucleoside analogue CP-4055 in two phase I trials using a daily for 5 days schedule and three intermittent weekly or biweekly schedules. Cancer Research. 65. 936–936. 2 indexed citations

20.

Dueland, Svein, Marianne G. Guren, Dag Rune Olsen, Jan Peter Poulsen, & Kjell Magne Tveit. (2003). Radiation therapy induced changes in male sex hormone levels in rectal cancer patients. Radiotherapy and Oncology. 68(3). 249–253. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact